Literature DB >> 21330434

Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile.

Prerna Vohra1, Ian R Poxton.   

Abstract

Clostridium difficile is a major cause of nosocomial diarrhoea. The toxins that it produces (TcdA and TcdB) are responsible for the characteristic pathology of C. difficile infection (CDI), while its spores persist in the environment, causing its widespread transmission. Many different strains of C. difficile exist worldwide and the epidemiology of the strains is ever-changing: in Scotland, PCR ribotype 012 was once prevalent, but currently ribotypes 106, 001 and 027 are endemic. This study aimed to identify the differences among these ribotypes with respect to their growth, and toxin and spore production in vitro. It was observed that the hypervirulent ribotype 027 produces significantly more toxin than the other ribotypes in the exponential and stationary phases of growth. Further, the endemic strains produce significantly more toxins and spores than ribotype 012. Of note was the observation that tcdC expression did not decrease into the stationary phase of growth, implying that it may have a modulatory rather than repressive effect on toxin production. Further, the increased expression of tcdE in ribotype 027 suggests its importance in the release of the toxins. It can thus be concluded that several genotypic and phenotypic traits might synergistically contribute to the hypervirulence of ribotype 027. These observations might suggest a changing trend towards increased virulence in the strains currently responsible for CDI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330434     DOI: 10.1099/mic.0.046243-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  44 in total

1.  Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants.

Authors:  Ingegerd Adlerberth; Haihui Huang; Erika Lindberg; Nils Åberg; Bill Hesselmar; Robert Saalman; Carl Erik Nord; Agnes E Wold; Andrej Weintraub
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

2.  A Nutrient-Regulated Cyclic Diguanylate Phosphodiesterase Controls Clostridium difficile Biofilm and Toxin Production during Stationary Phase.

Authors:  Erin B Purcell; Robert W McKee; David S Courson; Elizabeth M Garrett; Shonna M McBride; Richard E Cheney; Rita Tamayo
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

3.  Evaluation of growth and sporulation of a non-toxigenic strain of Clostridioides difficile (Z31) and its shelf viability.

Authors:  Carlos Augusto Oliveira Júnior; Rodrigo Otávio Silveira Silva; Diogo Soares Gonçalves Cruz; Isadora Honorato Pires; Guilherme Guerra Alves; Francisco Carlos Faria Lobato
Journal:  Braz J Microbiol       Date:  2018-12-18       Impact factor: 2.476

Review 4.  The potential for emerging therapeutic options for Clostridium difficile infection.

Authors:  Harsh Mathur; Mary C Rea; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Gut Microbes       Date:  2014

5.  Functional characterization of Clostridium difficile spore coat proteins.

Authors:  Patima Permpoonpattana; Jutarop Phetcharaburanin; Anna Mikelsone; Marcin Dembek; Sisareuth Tan; Marie-Clémence Brisson; Roberto La Ragione; Alain R Brisson; Neil Fairweather; Huynh A Hong; Simon M Cutting
Journal:  J Bacteriol       Date:  2013-01-18       Impact factor: 3.490

6.  Bile acid sensitivity and in vivo virulence of clinical Clostridium difficile isolates.

Authors:  Brittany B Lewis; Rebecca A Carter; Eric G Pamer
Journal:  Anaerobe       Date:  2016-05-27       Impact factor: 3.331

7.  CodY-Dependent Regulation of Sporulation in Clostridium difficile.

Authors:  Kathryn L Nawrocki; Adrianne N Edwards; Nadine Daou; Laurent Bouillaut; Shonna M McBride
Journal:  J Bacteriol       Date:  2016-07-13       Impact factor: 3.490

8.  Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?

Authors:  J L Leslie; S H Cohen; J V Solnick; C R Polage
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-20       Impact factor: 3.267

9.  Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain.

Authors:  T J Carlson; D Blasingame; A J Gonzales-Luna; F Alnezary; K W Garey
Journal:  Anaerobe       Date:  2019-12-19       Impact factor: 3.331

Review 10.  Clostridium difficile Infection: An Epidemiology Update.

Authors:  Ana C De Roo; Scott E Regenbogen
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.